• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2020年10月至12月在美因河畔法兰克福对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进行的监测显示,病毒具有高度多样性,包括B.1.1.70和B.1.1.7中的刺突突变N501Y。

Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7.

作者信息

Widera Marek, Mühlemann Barbara, Corman Victor M, Toptan Tuna, Beheim-Schwarzbach Jörn, Kohmer Niko, Schneider Julia, Berger Annemarie, Veith Talitha, Pallas Christiane, Bleicker Tobias, Goetsch Udo, Tesch Julia, Gottschalk Rene, Jones Terry C, Ciesek Sandra, Drosten Christian

机构信息

Institute for Medical Virology, University Hospital Frankfurt, Goethe University Frankfurt am Main, 60596 Frankfurt am Main, Germany.

German Centre for Infection Research (DZIF), Institute of Virology, Charité-Universitätsmedizin Berlin, Humboldt-Universität zu Berlin, 10117 Berlin, Germany.

出版信息

Microorganisms. 2021 Apr 2;9(4):748. doi: 10.3390/microorganisms9040748.

DOI:10.3390/microorganisms9040748
PMID:33918332
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8065810/
Abstract

BACKGROUND

International travel is a major driver of the introduction and spread of SARS-CoV-2.

AIM

To investigate SARS-CoV-2 genetic diversity in the region of a major transport hub in Germany, we characterized the viral sequence diversity of the SARS-CoV-2 variants circulating in Frankfurt am Main, the city with the largest airport in Germany, from the end of October to the end of December 2020.

METHODS

In total, we recovered 136 SARS-CoV-2 genomes from nasopharyngeal swab samples. We isolated 104 isolates that were grown in cell culture and RNA from the recovered viruses and subjected them to full-genome sequence analysis. In addition, 32 nasopharyngeal swab samples were directly sequenced.

RESULTS AND CONCLUSION

We found 28 different lineages of SARS-CoV-2 circulating during the study period, including the variant of concern B.1.1.7 (Δ69/70, N501Y). Six of the lineages had not previously been observed in Germany. We detected the spike protein (S) deletion Δ69/Δ70 in 15% of all sequences, a four base pair (bp) deletion (in 2.9% of sequences) and a single bp deletion (in 0.7% of sequences) in ORF3a, leading to ORF3a truncations. In four sequences (2.9%), an amino acid deletion at position 210 in S was identified. In a single sample (0.7%), both a 9 bp deletion in ORF1ab and a 7 bp deletion in ORF7a were identified. One sequence in lineage B.1.1.70 had an N501Y substitution while lacking the Δ69/70 in S. The high diversity of sequences observed over two months in Frankfurt am Main highlights the persisting need for continuous SARS-CoV-2 surveillance using full-genome sequencing, particularly in cities with international airport connections.

摘要

背景

国际旅行是严重急性呼吸综合征冠状病毒2(SARS-CoV-2)传入和传播的主要驱动因素。

目的

为了调查德国一个主要交通枢纽地区的SARS-CoV-2基因多样性,我们对2020年10月底至12月底在德国最大机场所在城市美因河畔法兰克福流行的SARS-CoV-2变体的病毒序列多样性进行了表征。

方法

我们总共从鼻咽拭子样本中获得了136个SARS-CoV-2基因组。我们分离出104株在细胞培养中生长的毒株,并从回收的病毒中提取RNA,对其进行全基因组序列分析。此外,对32份鼻咽拭子样本进行了直接测序。

结果与结论

我们发现在研究期间有28种不同的SARS-CoV-2谱系在传播,包括值得关注的变体B.1.1.7(Δ69/70,N501Y)。其中6个谱系此前在德国未曾被观察到。我们在所有序列的15%中检测到刺突蛋白(S)缺失Δ69/Δ70,在开放阅读框3a(ORF3a)中有一个四碱基对(bp)缺失(在2.9%的序列中)和一个单碱基对缺失(在0.7%的序列中),导致ORF3a截短。在4个序列(2.9%)中,鉴定出S蛋白第210位氨基酸缺失。在单个样本(0.7%)中,同时鉴定出ORF1ab中的9 bp缺失和ORF7a中的7 bp缺失。B.1.1.70谱系中的一个序列有N501Y替换,而S蛋白中没有Δ69/70缺失。在美因河畔法兰克福两个月内观察到的序列高度多样性凸显了持续使用全基因组测序进行SARS-CoV-2监测的持续必要性,特别是在有国际机场连接的城市。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a87/8065810/4fb7228b2b18/microorganisms-09-00748-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a87/8065810/042b8e6bbb19/microorganisms-09-00748-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a87/8065810/93cccb7b794f/microorganisms-09-00748-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a87/8065810/4fb7228b2b18/microorganisms-09-00748-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a87/8065810/042b8e6bbb19/microorganisms-09-00748-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a87/8065810/93cccb7b794f/microorganisms-09-00748-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0a87/8065810/4fb7228b2b18/microorganisms-09-00748-g003.jpg

相似文献

1
Surveillance of SARS-CoV-2 in Frankfurt am Main from October to December 2020 Reveals High Viral Diversity Including Spike Mutation N501Y in B.1.1.70 and B.1.1.7.2020年10月至12月在美因河畔法兰克福对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进行的监测显示,病毒具有高度多样性,包括B.1.1.70和B.1.1.7中的刺突突变N501Y。
Microorganisms. 2021 Apr 2;9(4):748. doi: 10.3390/microorganisms9040748.
2
Real-Time RT-PCR Allelic Discrimination Assay for Detection of N501Y Mutation in the Spike Protein of SARS-CoV-2 Associated with B.1.1.7 Variant of Concern.实时 RT-PCR 等位基因鉴别检测法用于检测与关注变异株 B.1.1.7 相关的 SARS-CoV-2 刺突蛋白 N501Y 突变。
Microbiol Spectr. 2022 Feb 23;10(1):e0068121. doi: 10.1128/spectrum.00681-21. Epub 2022 Feb 16.
3
Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020.2020 年 10 月至 11 月英国 SARS-CoV-2 N501Y 突变株的早期传播能力评估。
Euro Surveill. 2021 Jan;26(1). doi: 10.2807/1560-7917.ES.2020.26.1.2002106.
4
Genomic Diversity of SARS-CoV-2 in Algeria and North African Countries: What We Know So Far and What We Expect?阿尔及利亚和北非国家新冠病毒的基因组多样性:我们目前所知及预期如何?
Microorganisms. 2022 Feb 18;10(2):467. doi: 10.3390/microorganisms10020467.
5
Genomic Surveillance of SARS-CoV-2 Lineages Indicates Early Circulation of P.1 (Gamma) Variant of Concern in Southern Brazil.对 SARS-CoV-2 谱系的基因组监测表明,在巴西南部早期传播了令人关注的 P.1(Gamma)变体。
Microbiol Spectr. 2022 Feb 23;10(1):e0151121. doi: 10.1128/spectrum.01511-21. Epub 2022 Feb 16.
6
Phylogenetic and amino acid signature analysis of the SARS-CoV-2s lineages circulating in Tunisia.突尼斯流行的 SARS-CoV-2 谱系的系统发育和氨基酸特征分析。
Infect Genet Evol. 2022 Aug;102:105300. doi: 10.1016/j.meegid.2022.105300. Epub 2022 May 10.
7
The SARS-CoV-2 Delta (B.1.617.2) variant with spike N501Y mutation in the shadow of Omicron emergence.在奥密克戎毒株出现的背景下,带有刺突蛋白N501Y突变的严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)德尔塔(B.1.617.2)变种。
Heliyon. 2022 Dec;8(12):e12650. doi: 10.1016/j.heliyon.2022.e12650. Epub 2022 Dec 24.
8
Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.通过 ddPCR 特异性等位基因鉴别检测 N501Y 和其他 SARS-CoV-2 突变可鉴定华盛顿州的 B.1.1.7 谱系。
J Med Virol. 2021 Oct;93(10):5931-5941. doi: 10.1002/jmv.27155. Epub 2021 Jul 3.
9
Temporal-Geographical Dispersion of SARS-CoV-2 Spike Glycoprotein Variant Lineages and Their Functional Prediction Using Approach.利用 方法预测 SARS-CoV-2 刺突糖蛋白变异株的时空地理分布及其功能。
mBio. 2021 Oct 26;12(5):e0268721. doi: 10.1128/mBio.02687-21.
10
Emergency SARS-CoV-2 Variants of Concern: Novel Multiplex Real-Time RT-PCR Assay for Rapid Detection and Surveillance.关注的紧急 SARS-CoV-2 变异株:用于快速检测和监测的新型多重实时 RT-PCR 检测方法。
Microbiol Spectr. 2022 Feb 23;10(1):e0251321. doi: 10.1128/spectrum.02513-21.

引用本文的文献

1
Special Issue "SARS-CoV-2: Epidemiology and Pathogenesis": Editorial.特刊“严重急性呼吸综合征冠状病毒2:流行病学与发病机制”:社论。
Microorganisms. 2023 Apr 3;11(4):927. doi: 10.3390/microorganisms11040927.
2
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform.使用优化的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)表型筛选平台鉴定新型抗病毒药物候选物。
iScience. 2023 Feb 17;26(2):105944. doi: 10.1016/j.isci.2023.105944. Epub 2023 Jan 7.
3
Quantitative determination of the electron beam radiation dose for SARS-CoV-2 inactivation to decontaminate frozen food packaging.

本文引用的文献

1
Limited Neutralization of Authentic Severe Acute Respiratory Syndrome Coronavirus 2 Variants Carrying E484K In Vitro.体外实验中,对携带 E484K 变异的真实严重急性呼吸综合征冠状病毒 2 型的有限中和作用。
J Infect Dis. 2021 Oct 13;224(7):1109-1114. doi: 10.1093/infdis/jiab355.
2
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings.评估 SARS-CoV-2 在实验室环境下的稳定性和失活动力学。
Med Microbiol Immunol. 2021 Aug;210(4):235-244. doi: 10.1007/s00430-021-00716-3. Epub 2021 Jul 1.
3
SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies.
定量测定电子束辐射剂量以灭活 SARS-CoV-2 对冷冻食品包装进行消毒。
Virol Sin. 2022 Dec;37(6):823-830. doi: 10.1016/j.virs.2022.10.007. Epub 2022 Oct 26.
4
Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics.对携带 B.1 和 B.1.617.2 刺突突变的临床分离株和重组 SARS-CoV-2 的分子分析表明,非刺突突变可能在感染动力学中起作用。
Viruses. 2022 Sep 12;14(9):2017. doi: 10.3390/v14092017.
5
Comparative genomics, evolutionary epidemiology, and RBD-hACE2 receptor binding pattern in B.1.1.7 (Alpha) and B.1.617.2 (Delta) related to their pandemic response in UK and India.比较基因组学、进化流行病学以及 B.1.1.7(阿尔法)和 B.1.617.2(德尔塔)与它们在英国和印度大流行应对相关的 RBD-hACE2 受体结合模式。
Infect Genet Evol. 2022 Jul;101:105282. doi: 10.1016/j.meegid.2022.105282. Epub 2022 Apr 13.
6
Development of antibody resistance in emerging mutant strains of SARS CoV-2: Impediment for COVID-19 vaccines.新兴 SARS-CoV-2 突变株抗体耐药性的发展:对 COVID-19 疫苗的阻碍。
Rev Med Virol. 2022 Sep;32(5):e2346. doi: 10.1002/rmv.2346. Epub 2022 Apr 13.
7
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q.抗体介导的对含有 L452R 和 T478K/E484Q 的真实 SARS-CoV-2 B.1.617 变异株的中和作用。
Viruses. 2021 Aug 26;13(9):1693. doi: 10.3390/v13091693.
8
Generation of a Sleeping Beauty Transposon-Based Cellular System for Rapid and Sensitive Screening for Compounds and Cellular Factors Limiting SARS-CoV-2 Replication.基于睡美人转座子的细胞系统的构建,用于快速灵敏地筛选限制严重急性呼吸综合征冠状病毒2(SARS-CoV-2)复制的化合物和细胞因子。
Front Microbiol. 2021 Jul 29;12:701198. doi: 10.3389/fmicb.2021.701198. eCollection 2021.
9
Estimating infectiousness throughout SARS-CoV-2 infection course.估算 SARS-CoV-2 感染全程的传染性。
Science. 2021 Jul 9;373(6551). doi: 10.1126/science.abi5273. Epub 2021 May 25.
SARS-CoV-2 变体 B.1.351 和 P.1 逃避中和抗体。
Cell. 2021 Apr 29;184(9):2384-2393.e12. doi: 10.1016/j.cell.2021.03.036. Epub 2021 Mar 20.
4
Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7.社区检出的 SARS-CoV-2 谱系 B.1.1.7 病例死亡率增加。
Nature. 2021 May;593(7858):270-274. doi: 10.1038/s41586-021-03426-1. Epub 2021 Mar 15.
5
SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines.SARS-CoV-2 变异株 B.1.1.7 易被原始刺突疫苗诱导产生的中和抗体中和。
Cell Host Microbe. 2021 Apr 14;29(4):529-539.e3. doi: 10.1016/j.chom.2021.03.002. Epub 2021 Mar 5.
6
Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7.SARS-CoV-2 变体 B.1.351 和 B.1.1.7 的抗体抗性。
Nature. 2021 May;593(7857):130-135. doi: 10.1038/s41586-021-03398-2. Epub 2021 Mar 8.
7
Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England.在英格兰,估计 SARS-CoV-2 谱系 B.1.1.7 的传染性和影响。
Science. 2021 Apr 9;372(6538). doi: 10.1126/science.abg3055. Epub 2021 Mar 3.
8
Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies.全面绘制影响多克隆人血浆抗体识别的 SARS-CoV-2 受体结合域突变图谱。
Cell Host Microbe. 2021 Mar 10;29(3):463-476.e6. doi: 10.1016/j.chom.2021.02.003. Epub 2021 Feb 8.
9
Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera.BNT162b2 疫苗诱导的血清对 SARS-CoV-2 刺突 69/70 缺失、E484K 和 N501Y 变异株的中和作用。
Nat Med. 2021 Apr;27(4):620-621. doi: 10.1038/s41591-021-01270-4. Epub 2021 Feb 8.
10
One Year of SARS-CoV-2: How Much Has the Virus Changed?新冠病毒的一年:病毒发生了多大变化?
Biology (Basel). 2021 Jan 26;10(2):91. doi: 10.3390/biology10020091.